Kyle Jenne serves as Executive at AKCEA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Kyle Jenne has executed 5 insider transactions totaling $22.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 12, 2020 involved transacting 52,012 shares valued at $944.0K.
Kyle Jenne currently holds 52,012 shares of AKCEA THERAPEUTICS, INC. (AKCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kyle Jenne has been a net seller of AKCA stock. They have purchased $0 and sold $22.2K worth of shares.
Kyle Jenne's most recent insider trade was on Oct 12, 2020, when they sold 52,012 shares at $18.15 per share.
Get notified when new Form 4 filings are submitted
| $18.12 |
| Discretionary |
| Mar 23, 2020 | AKCA | $9.2K | Sale | 779 | $11.75 | Discretionary |
| Mar 19, 2020 | AKCA | $0 | Award | 16,800 | $N/A | Discretionary |
| Oct 21, 2019 | AKCA | $0 | Award | 25,000 | $N/A | Discretionary |